SAB Biotherapeutics, Inc. SABS
NASDAQ · United States · Health Technology
$2.98-0.08 (-2.61%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.28 | -0.28 | +1.1% | $0 | — | +3.4%$3.77→$3.90 |
| Q1 2026 | 2026-05-12 | -0.35 | -0.20 | -75.0% | — | — | +6.5%$3.72→$3.96 |
| Q4 2025 | 2026-03-09 | -0.41 | -0.17 | -141.2% | — | — | +8.2%$3.79→$4.10 |
| Q3 2025 | 2025-11-14 | 0.50 | -0.46 | +208.7% | — | — | +12.9%$3.10→$3.50 |
| Q1 2025 | 2025-05-09 | -0.56 | -1.07 | +47.7% | — | — | — |
| Q4 2024 | 2025-03-31 | -0.98 | -1.21 | +19.0% | — | — | — |
| Q1 2024 | 2024-05-20 | -1.14 | -0.98 | -16.3% | — | — | — |
| Q4 2023 | 2024-03-29 | -6.39 | -0.64 | -898.4% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.